Our work illustrated that DHRS4-AS1 expression is elevated in PRAD tissues versus normal controls, correlated with TMBIM6 in a positive manner, and inversely with miR-222-3p. This evidence concerns the gene TMBIM6 and prostate adenocarcinoma.